Results 71 to 80 of about 581,647 (319)

Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. [PDF]

, 2020
BackgroundAn outbreak of COVID-19 in Iran has spread throughout the country. Identifying the epidemiological characteristics of this disease will help to make appropriate decisions and thus control the epidemic. The aim of this study was characterization
Abbaszadeh, Sepideh, Alimohamadi, Yousef, Alishiri, GholamHossein, Bagheri, Mahdi, Dorostkar, Ruhollah, Ebrahimnia, Mehdi, Farnoosh, Gholamreza, Gouvarchin Ghaleh, Hadi Esmaeili, Heydari, Soleyman, Hosseini Zijoud, Seyed Reza, Izadi, Morteza, Jafari, Nematollah Jonaidi, Jalali Farahani, Alireza, Nikpouraghdam, Mohamad, Qazvini, Ali, Samadinia, Hossein, Sepandi, Mojtaba, Shahriary, Alireza, Taghdir, Maryam, Tat, Mahdi   +19 more
core   +1 more source

Priapism in a patient with coronavirus disease 2019 (COVID-19)

The American Journal of Emergency Medicine, 2021
Thromboembolic complications related to SARS-CoV-2 have been extensively reported. They include deep vein thrombosis, pulmonary embolism, ischemic stroke, and acute coronary syndrome. Penile thrombosis has not been reported as a thrombotic complication of SARS-CoV-2 infection with hypercoagulability.
Lamamri, Myriam, Chebbi, Ala, Mamane, Jordan, Abbad, Sofia, Munuzzolini, Milena, Sarfati, Florence, Legriel, Stéphane   +6 more
openaire   +4 more sources

A role for quercetin in coronavirus disease 2019 (COVID‐19) [PDF]

Phytotherapy Research, 2020
Several months ago, an outbreak of pneumonia of unknown aetiology was detected in Wuhan City (China) and the aetiological agent of the atypical pneumonia was isolated by the Chinese authorities as novel coronavirus (2019‐nCoV or SARS‐CoV‐2). The WHO announced this new disease was to be known as “COVID‐19.” When looking for new antiviral compounds ...
Derosa, Giuseppe, Maffioli, Pamela, DAngelo, Angela, Di Pierro, Francesco   +3 more
openaire   +3 more sources

COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. [PDF]

, 2020
Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or
Greenland, John R, London, Martin J, Michelow, Marilyn D, Wang, Linlin   +3 more
core  

Covid-19 and its impact on digital marketing [PDF]

, 2022
The coronavirus disease 2019 (COVID-19), is a new type of coronavirus spreading exponentially globally. It was started in December 2019 in Wuhan, China, which caused severe acute respiratory \ud syndrome coronavirus 2 (SARS-CoV-2) (Dashraath et al ...
Abdul Rashid, Umi Kartini, Abu Seman, Noor Aslinda, Ahmad Effendi, Farah Adibah, Farradia, Yuary, Harun, Amran, Hasim, Muhammad Asyraf   +5 more
core  

Vulnerability of deep neural networks for detecting COVID-19 cases from chest X-ray images to universal adversarial attacks [PDF]

, 2020
Under the epidemic of the novel coronavirus disease 2019 (COVID-19), chest X-ray computed tomography imaging is being used for effectively screening COVID-19 patients.
Hirano, Hokuto, Koga, Kazuki, Takemoto, Kazuhiro   +2 more
core   +3 more sources

Coronavirus disease 2019 (COVID-19) and headaches

Rinsho Shinkeigaku, 2020
Over the course of the new coronavirus infectious disease (coronavirus disease 2019; COVID-19) pandemic, our social situation has been changing dramatically, in addition to the substantial efforts made for the early and appropriate management of COVID-19 and preventing this infection spreading.
openaire   +3 more sources

Coronavirus disease 2019 (COVID-19): a clinical update [PDF]

Frontiers of Medicine, 2020
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. It caused a total of 80 868 confirmed cases and 3101 deaths in Chinese mainland until March 8, 2020. This novel virus spread mainly through respiratory droplets and close contact.
Zhou, Min, Zhang, Xinxin, Qu, Jieming
openaire   +2 more sources

COVID‐19 Vaccination is not Associated with the Development of Idiopathic Inflammatory Myositis in U.S. Veterans

Arthritis Care &Research, Accepted Article.
Objective Several case reports have proposed a potential association between COVID‐19 vaccination and the subsequent development of idiopathic inflammatory myositis (IIM). This study examined prior COVID‐19 vaccination in US Veterans who developed new‐onset IIM compared to those without new‐onset IIM.
Caleb Hernández, Naomi Schlesinger, Jorge Rojas, Jessica A. Walsh, Tawnie J Braaten, Gary A Kunkel, Makoto Jones, Brian C Sauer, Julio Facelli, Grant W. Cannon, Dorota Lebiedz‐Odrobina   +10 more
wiley   +1 more source

Mesenteric Ischemia in a Case of COVID-19

Case Reports in Clinical Practice, 2021
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now a global threat. Various papers have addressed the pulmonary symptoms of this viral disease.
Shilan Azhdeh, Mohammad-Ali Mohammadi-Vajari, Mohammadreza Khaleghi   +2 more
doaj   +1 more source